Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Current Gene Therapy|August 13, 2015
Biodistribution of LV-TSTA transduced rat bone marrow cells used for "ex-vivo" regional gene therapy for bone repairFarhang Alaee, Cynthia Bartholomae, Osamu Sugiyama, et al.Nature Methods|December 1, 2007
High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR)Manfred Schmidt, Kerstin Schwarzwaelder, Cynthia Bartholomae, et al.EMBO Molecular Medicine|January 19, 2011
Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cellLuca Biasco, Alessandro Ambrosi, Danilo Pellin, et al.Nature Biotechnology|May 30, 2006
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integrationEugenio Montini, Daniela Cesana, Manfred Schmidt, et al.Plos One|January 5, 2011
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusionClaudia Cattoglio, Giulietta Maruggi, Cynthia Bartholomae, et al.Plos One|June 28, 2007
Real-time definition of non-randomness in the distribution of genomic eventsUlrich Abel, Annette Deichmann, Cynthia Bartholomae, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 21, 2014
Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivoDaniela Cesana, Marco Ranzani, Monica Volpin, et al.Nature Medicine|February 24, 2006
Effective gene therapy with nonintegrating lentiviral vectorsRafael J Yáñez-Muñoz, Kamaljit S Balaggan, Angus MacNeil, et al.Current Gene Therapy|November 28, 2014
Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell diseaseOlivier Negre, Cynthia Bartholomae, Yves Beuzard, et al.The Journal of Clinical Investigation|August 9, 2008
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patientsSteven J Howe, Marc R Mansour, Kerstin Schwarzwaelder, et al.Pageof 1